Herbals Should Be Subject To Same Standards As Drugs – JAMA Article
This article was originally published in The Tan Sheet
Executive Summary
Herbal products should be subject to the same premarket evaluation of safety and efficacy as drugs, the head of NCCAM and other NIH leaders argue in an article on ethical issues in complementary and alternative medicine research